ArticleCurrent oncology (Toronto, Ont.)2022

Identification of Potential Predictors of Prognosis and Sorafenib-Associated Survival Benefits in Patients with Hepatocellular Carcinoma after Transcatheter Arterial Chemoembolization.

Kun He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.